Real-time enrollment status for this egfr mutant advanced non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:15 PM UTC
| NCT Number | NCT05394831 |
| Recruiting Status | Recruiting |
| Condition | EGFR Mutant Advanced Non-small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 1 sites in the US |
| Sponsor | J Ints Bio |
| Last Updated on CT.gov | May 16, 2025 (May 16, 2025) |
As of July 13, 2026: Clinical trial NCT05394831 is currently recruiting participants. This clinical trial study for egfr mutant advanced non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by J Ints Bio. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05394831 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05394831 was last updated May 16, 2025 (May 16, 2025). HelloStudys verifies this status automatically.